InnoCare Pharma Revenue
Biotechnology Research • 
Changping District, Beijing, China • 101-200 Employees
InnoCare Pharma revenue & valuation
| Annual revenue | $208,971 |
| Revenue per employee | $2,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $668,707 |
| Total funding | No funding |
Key Contacts at InnoCare Pharma
Nghia Nguyen
Chief Executive Officer
Jinling Hu
Director Of Clinical Project Management
Yi Du
Director Of Business Development
Jimmy Shi
Head Of Production
Eric Zhang
Engineering Operation Head, Executive Director
Bo Cui
Assistant Director Of Process Chemistry
Field Tian
Ta Director
Shin Hou
Director Of Biologics Discovery At Innocare
Jie Gao
Director Of Medical Research
Jasmine Cui
Co-Founder, Chairwoman & Ceo
Company overview
| Headquarters | Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing, Beijing, CN |
| Phone number | +861066609999 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, CMC, Pharmacology, Medical Research, Medicinal Chemistry, Clinical Development, Autoimmune Diseases, Discovery Biology, New Drug Discovery, Oncology Diseases |
| Founded | 2015 |
| Employees | 101-200 |
| Socials |
InnoCare Pharma Email Formats
InnoCare Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@innocarepharma.com), used 88.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@innocarepharma.com | 88.7% |
{first initial}.{last name} | j.doe@innocarepharma.com | 11.3% |
About InnoCare Pharma
InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the world's top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
InnoCare Pharma has 41 employees across 13 departments.
Departments
Number of employees
InnoCare Pharma Tech Stack
Discover the technologies and tools that power InnoCare Pharma's digital infrastructure, from frameworks to analytics platforms.
Security
Miscellaneous
Web servers
France
United Kingdom
Italy
CanadaFrequently asked questions
4.8
40,000 users
